Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Coronary Artery Bypass Graft (CABG) Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Off-Pump CABG , On-Pump CABG , Minimally Invasive Direct Coronary Artery Bypass , Robotic-Assisted CABG), By Procedure Type (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery), By Graft Type (Saphenous Vein Grafts, Internal Mammary Artery Grafts, Radial Artery Grafts), By End User (Hospitals, Cardiology Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Coronary Artery Bypass Graft (CABG) Market size is forecast to increase from $25.75 Billion in 2026 to $34.97 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006567
Pages: 224 Pages

Corneal Topographers Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Placido Reflection Systems, Scanning Slit Systems, Scheimpflug Imaging Systems, Hybrid Multi-modal Systems), By Portability (Tabletop Systems, Handheld), By Application (Refractive Surgery Planning, Cataract Surgery IOL Selection, Keratoconus & Ectasia Diagnosis, Corneal Edema & Dystrophy Assessment, Contact Lens Fitting ), By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers , Optometry & Vision-care Centers, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Corneal Topographers Market size is forecast to increase from $890.02 Million in 2026 to $1345.32 Million in 2034 at a CAGR of 5.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006566
Pages: 221 Pages

Corneal Pachymetry Market Size, Share and Growth Outlook, 2026: Analysis By Modality (Handheld , Desktop ), By Measurement Method (Ultrasonic Pachymetry , Optical Pachymetry ), By Clinical Application (Glaucoma Diagnostics and Intraocular Pressure , Refractive Surgery Planning , Keratoconus and Ectasia Screening, Post-operative Corneal Edema Monitoring, Corneal Transplant Evaluation ), By End-User (Ophthalmic Specialty Clinics and Optometry Centers, Multi-Specialty Hospitals, Ambulatory Surgical Centers , Academic, Vision Care, and Ocular Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Corneal Pachymetry Market size is forecast to increase from $608.45 Million in 2026 to $845.6 Million in 2034 at a CAGR of 4.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006565
Pages: 216 Pages

Corneal Implants Market Size, Share and Growth Outlook, 2026: Analysis By Implant Type (Human Donor Corneal Implants , Artificial Corneal Implants ), By Material Composition (PMMA , Hydrogels and Hydrophilic Acrylics, Collagen-Based Biomaterials ), By Surgical Procedure Method (Penetrating Keratoplasty , Endothelial Keratoplasty , Anterior Lamellar Keratoplasty , Intrastromal Corneal Ring Segments ), By Disease Indication (Keratoconus and Ectatic Corneal Diseases, Fuchs' Endothelial Dystrophy, Bullous Keratopathy , Infectious Keratitis and Corneal Ulcers, Trauma and Mechanical Corneal Injuries), By End-User (Hospitals and Tertiary Eye Care Centers, Ophthalmic Specialty Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Corneal Implants Market size is forecast to increase from $560.22 Million in 2026 to $955.39 Million in 2034 at a CAGR of 6.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006564
Pages: 226 Pages

Cord Blood Banking Services Market Size, Share and Growth Outlook, 2026: Analysis By Bank Type (Private Cord Blood Banks, Public Cord Blood Banks, Hybrid Cord Blood Banks), By Component Type (Cord Blood, Cord Tissue, Placental Blood ), By Service Phase (Collection and Transportation Services, Processing and Analysis Services, Cryopreservation and Storage Services), By Therapeutic Application (Cancers , Blood Disorders , Immune Deficiencies and Autoimmune Disorders, Metabolic , Regenerative Medicine and Clinical Trials), By End-User (Hospitals and Specialized Transplant Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Cord Blood Banking Services Market size is forecast to increase from $32.01 Billion in 2026 to $58.81 Billion in 2034 at a CAGR of 7.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006563
Pages: 226 Pages

CoQ10 Supplement Market Size, Share and Growth Outlook, 2026: Analysis By Product Type: (Ubiquinone, Ubiquinol), By Application: (Dietary Supplements, Cosmetics and Personal Care, Pharmaceuticals, Functional Food and Beverages, Animal Health), By Dosage Form: (Softgels, Capsules, Tablets, Powder, Liquid, Gummies), By Grade: (Food Grade, Pharmaceutical Grade) Companies, and Country Forecast, 2021 to 2034

Global CoQ10 Supplement Market size is forecast to increase from $915.14 Million in 2026 to $1976 Million in 2034 at a CAGR of 10.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006562
Pages: 212 Pages

COPD and Asthma Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class: (Bronchodilators, Corticosteroids, Leukotriene Modifiers, Anti-IgE and Anti-IL Monoclonal Antibodies, Combination Therapy, Antibiotics, Mucolytics), By Indication: (Asthma, Chronic Obstructive Pulmonary Disease ), By Route of Administration: (Inhalation, Oral, Parenteral), By Drug Availability: (Prescription Drugs, Over-the-Counter ), By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global COPD and Asthma Therapeutics Market size is forecast to increase from $111.87 Billion in 2026 to $229.54 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006561
Pages: 228 Pages

COPD and Asthma Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type: (Inhalers, Nebulizers, Oxygen Delivery Systems, Peak Flow Meters, Spacer Devices), By Indication: (Asthma, Chronic Obstructive Pulmonary Disease ), By Mode of Operation: (Conventional Devices, Digital), By Age Group: (Pediatric, Adult, Geriatric), By End-User: (Hospitals and Clinics, Home Healthcare, Ambulatory Surgical Centers, Pulmonary Rehabilitation Centers, Retail Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global COPD and Asthma Devices Market size is forecast to increase from $51.11 Billion in 2026 to $73.24 Billion in 2034 at a CAGR of 4.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006560
Pages: 219 Pages

Conversational AI In Healthcare Market Size, Share and Growth Outlook, 2026: Analysis By Component (Chatbots, Virtual Assistants, Speech Recognition Systems, Services ), By Technology (Natural Language Processing , Machine Learning , Speech Recognition and Generation, Generative AI and Large Language Models ), By Application (Patient Engagement and Support, Clinical Workflow Automation, Symptom Checking and Triage, Appointment Scheduling and Reminders, Chronic Disease Management, Medical Transcription and Documentation), By End User (Healthcare Providers , Healthcare Payers , Pharmaceutical and Life Sciences Companies, Patients and Home Care Users) Companies, and Country Forecast, 2021 to 2034

Global Conversational AI In Healthcare Market size is forecast to increase from $20.99 Billion in 2026 to $121.94 Billion in 2034 at a CAGR of 24.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006559
Pages: 228 Pages

Controlled Release Drug Delivery Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Matrix Systems , Reservoir Systems, Microencapsulation, Transdermal Systems, Targeted Nano , Osmotic Pump Systems , Implantable Delivery Systems), By Route of Administration (Oral Controlled-Release, Parenteral , Transdermal, Inhalation, Ocular), By Therapeutic Area (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Autoimmune Diseases, Metabolic Disorders), By End User (Pharmaceutical and Biotechnology Companies, Hospitals and Specialized Clinics, Research and Academic Institutes) Companies, and Country Forecast, 2021 to 2034

Global Controlled Release Drug Delivery Market size is forecast to increase from $83.12 Billion in 2026 to $195.73 Billion in 2034 at a CAGR of 11.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006558
Pages: 222 Pages